Kerry Group Investor Presentation — February 2021 - Kerry Group

Document content

16 February 2021Preliminary

Disclaimer: Forward Looking Statements

This presentation/announcement may contain forward looking statements with projections regarding, among other things, the

Group’s strategy, revenues, earnings, trading profit, trading margin, finance costs, tax rate, capital expenditure, dividends , cash

flow, net debt or other financial measures, the impact of foreign exchange fluctuations, the impact of raw material fluctuati ons

and other competitive pressures. These and other forward looking statements reflect management expectations based on

currently available data.

However, actual results will be influenced by, among other things, macro -economic conditions, food industry supply and demand

issues, foreign exchange fluctuations, raw material and commodity fluctuations, the successful acquisition and integration of new

businesses, the successful execution of business transformation programmes and other, as of today, unknown factors.

Therefore actual results may differ materially from these projections.

These forward looking statements speak only as of the date they were made and the Group undertakes no obligation to publicly

update any forward looking statement, whether as a result of new information, future events or otherwise.

©Kerry 2021 | 2| Marguerite Larkin,

Chief Financial OfficerEdmond Scanlon,

Chief Executive OfficerPreliminary Statement of Results 2020

Strong Recovery and Continued Strategic Progression

Q4Investment in Rome,

GeorgiaNew Centre in

(FY -19% | Q4 -8%)Taste & Nutrition Channels Return To Growth Strategic Developments

•Retail –sustained strong growth

•Foodservice –continued recovery

supported by innovationsStrong progress in volume

returning to growth in Q4Good progress made across a

number of strategic fronts during

Business Review –Taste & Nutrition

Trading margin 14.2%

→Volume reduction of 3.0% in the full year with Q4 growth of 0.7%

→Foodservice channel volumes declined 19% with continued recovery (Q4: -8%)

Preview truncated — download the full document for the complete content.